





SLU-PP-332 (SLU)
5mg
120.00$
SLU-PP-332 is researched for its potential influence on energy expenditure and mitochondrial activity pathways. Studies explore its role in endurance-related metabolic signaling and cellular energy output models.
SLU-PP-332 (SLU)
Product Name: SLU-PP-332 (SLU)
Type: Metabolic Activation Research Compound
Research Focus:
PRECLINICAL RESEARCH COMPOUND: SLU-PP-332 is a synthetic pan-agonist of estrogen-related receptors (ERRα/β/γ) studied exclusively in murine models for its ability to activate an aerobic-exercise gene program, enhance mitochondrial function, and improve endurance and cardiometabolic phenotypes[1][2][3]. No human trials have been conducted as of November 2025. This educational protocol reflects published murine regimens using intraperitoneal administration.
Research Interest:
Endurance and performance signaling research
Mitochondrial activation pathway studies
Energy expenditure regulation models
Metabolic efficiency signaling networks
Scientific Interest:
Cellular oxidative capacity regulation
Substrate utilization signaling pathways
Mitochondrial biogenesis research
Reconstitution:
Evidence Base: Preclinical only—in vivo mouse studies with intraperitoneal dosing (25–50 mg/kg twice daily).
Reconstitute: Add 3.0 mLbacteriostatic water → ~1.67 mg/mLconcentration.
Murine dose range: 1250–2500 mcgdaily (for a 25 g mouse), administered in two divided doses.
Easy measuring: At 1.67 mg/mL, 1 unit = 0.01 mL ≈ 16.7 mcg on a U-100 insulin syringe.
Storage: Lyophilized: −20 °C (−4 °F); reconstituted: 2–8 °C (35.6–46.4 °F).
Cycle:
Murine-Equivalent Protocol (3 mL = ~1.67 mg/mL)
PHASE | DAILY DOSE (MCG) | PER-INJECTION DOSE (MCG) | UNITS PER INJECTION (ML) |
|---|---|---|---|
Weeks 1–2 | 1250 mcg | 625 mcg | 37.5 units (0.375 mL) |
Weeks 3–8 | 2500 mcg | 1250 mcg | 75 units (0.75 mL) |
Route & Frequency: Published murine studies used intraperitoneal administration twice daily (25–50 mg/kg)[1][2][3]. Daily mcg values above are expressed for a 25 g mouse. No reputable sources support once-daily subcutaneous use for this compound.
Reconstitution Steps
Draw 3.0 mL bacteriostatic water with a sterile syringe.
Inject slowly down the vial wall; avoid foaming.
Gently swirl/roll until dissolved (do not shake).
Label and refrigerate at 2–8 °C (35.6–46.4 °F), protected from light.
IMPORTANT NOTICE:
This product is intended strictly for laboratory research and is not for human or veterinary use. It is not intended to diagnose, treat, cure, or prevent any disease.

